Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity

Neuropsychopharmacology

Volumn 36, Issue 12, 2011, Pages 2551-2560

  Uys, Joachim D ^a   Knackstedt, Lori ^a   Hurt, Phelipe ^a   Tew, Kenneth D ^a   Manevich, Yefim ^a   Hutchens, Steven ^b   Townsend, Danyelle M ^b   Kalivas, Peter W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

accumbens; cocaine; glutathione; GST; redox; sensitization

Indexed keywords

COCAINE; CYSTEINE; GLUTATHIONE TRANSFERASE; KETOPROFEN; PROTEIN S;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GLUTATHINOYLATION; HOMEOSTASIS; INHIBITION KINETICS; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SENSITIZATION; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; COCAINE; GLUTATHIONE S-TRANSFERASE PI; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONAL PLASTICITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS;

EID: 80054762729     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.143     Document Type: Article

References (61)

1. Achat-Mendes C, Anderson KL, Itzhak Y (2007). Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 32: 531-541.
2. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD et al (1999). Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334. (Pubitemid 29110316)
3. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S et al (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6: 743-749. (Pubitemid 36792890)
4. Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ (2009). GSTpi expression in MPTPinduced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum. J Mol Neurosci 38: 114-127.
5. Chinta SJ, Rajagopalan S, Butterfield DA, Andersen JK (2006). In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's disease. Neurosci Lett 402: 137-141. (Pubitemid 43766441)
6. Devi BG, Chan AW (1997). Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci 60: 849-855. (Pubitemid 27153450)
7. Di Domenico F, Cenini G, Sultana R, Perluigi M, Uberti D, Memo M et al (2009). Glutathionylation of the pro-apoptotic protein p53 in Alzheimer0s disease brain: Implications for AD pathogenesis. Neurochem Res 34: 727-733.
8. Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, Zwiller J (2005). Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48: 965-974. (Pubitemid 40602604)
9. Dringen R, Pfeiffer B, Hamprecht B (1999). Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19: 562-569. (Pubitemid 29036007)
10. Fiaschi T, Cozzi G, Raugei G, Formigli L, Ramponi G, Chiarugi P (2006). Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 281: 22983-22991.
11. Gate L, Majumdar RS, Lunk A, Tew KD (2005). Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. Int J Cancer 113: 29-35. (Pubitemid 39507307)
12. Griffith OW (1999). Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27: 922-935. (Pubitemid 29507466)
13. Guindalini C, O'Gara C, Laranjeira R, Collier D, Castelo A, Vallada H et al (2005). A GSTP1 functional variant associated with cocaine dependence in a Brazilian population. Pharmacogenet Genomics 15: 891-893. (Pubitemid 41666771)
14. Hansen RE, Roth D, Winther JR (2009). Quantifying the global cellular thiol-disulfide status. Proc Natl Acad Sci USA 106: 422-427.
15. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR (1998). Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA 95: 5275-5280.
16. Humphries KM, Deal MS, Taylor SS (2005). Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J Biol Chem 280: 2750-2758. (Pubitemid 40189382)
17. Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598. (Pubitemid 44476856)
18. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P (2000). Redox state of glutathione in human plasma. Free Radic Biol Med 28: 625-635. (Pubitemid 30136044)
19. Kalivas PW (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572.
20. Kalivas PW, Duffy P, DuMars LA, Skinner C (1988). Behavioral and neurochemical effects of acute and daily cocaine. J Pharmacol Exp Ther 245: 485-492.
21. Kalivas PW, O'Brien C (2008). Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33: 166-180. (Pubitemid 350191316)
22. Kauer JA, Malenka RC (2007). Synaptic plasticity and addiction. Nat Rev Neurosci 8: 844-858. (Pubitemid 350006216)
23. Kitteringham NR, Powell H, Jenkins RE, Hamlett J, Lovatt C, Elsby R et al (2003). Protein expression profiling of glutathione S-transferase pi null mice as a strategy to identify potential markers of resistance to paracetamol-induced toxicity in the liver. Proteomics 3: 191-207. (Pubitemid 36254602)
24. Klatt P, Lamas S (2002). c-Jun regulation by S-glutathionylation. Methods Enzymol 348: 157-174. (Pubitemid 41103107)
25. Klepac N, Relja M, Klepac R, Hecimovic S, Babic T, Trkulja V (2007). Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: A cross-sectional study. J Neurol 254: 1676-1683.
26. Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S et al (2009). The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry 65: 841-845.
27. Kovacic P (2005). Role of oxidative metabolites of cocaine in toxicity and addiction: Oxidative stress and electron transfer. Med Hypotheses 64: 350-356. (Pubitemid 40022676)
28. Labib R, Turkall R, Abdel-Rahman MS (2002a). Endotoxin potentiates the hepatotoxicity of cocaine in male mice. J Toxicol Environ Health A 65: 977-993. (Pubitemid 34722095)
29. Labib R, Turkall R, Abdel-Rahman MS (2002b). Inhibition of cocaine oxidative metabolism attenuates endotoxin potentiation of cocaine mediated hepatotoxicity. Toxicology 179: 9-19. (Pubitemid 35245459)
30. Lopez-Mirabal HR, Winther JR (2008). Redox characteristics of the eukaryotic cytosol. Biochim Biophys Acta 1783: 629-640.
31. Macedo DS, Vasconcelos SM, Andrade-Neto M, Belchior LD, Honorio Junior JE, Goncalves DO et al (2010). Cocaine-induced status epilepticus and death generate oxidative stress in prefrontal cortex and striatum of mice. Neurochem Int 56: 183-187.
32. Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M et al (2007). Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci 27: 13968-13976. (Pubitemid 351377873)
33. Mallis RJ, Hamann MJ, Zhao W, Zhang T, Hendrich S, Thomas JA (2002). Irreversible thiol oxidation in carbonic anhydrase III: Protection by S-glutathiolation and detection in aging rats. Biol Chem 383: 649-662. (Pubitemid 34506302)
34. McBean GJ (2002). Cerebral cystine uptake: A tale of two transporters. Tr Pharmacol Sci 23: 299-302. (Pubitemid 34765619)
35. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD (2008). Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988.
36. Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A et al (2009). N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182-189.
37. Muriach M, Lopez-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, Romero FJ (2010). Cocaine causes memory and learning impairments in rats: Involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 114: 675-684.
38. Numa R, Kohen R, Poltyrev T, Yaka R (2008). Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 155: 649-658.
39. O'Connor E, Devesa A, Garcia C, Puertes IR, Pellin A, Vina JR (1995). Biosynthesis and maintenance of GSH in primary astrocyte cultures: Role of L-cystine and ascorbate. Brain Res 680: 157-163.
40. Osbild S, Bour J, Maunit B, Guillaume C, Asensio C, Muller JF et al (2008). Interaction of the electrophilic ketoprofenylglucuronide and ketoprofenyl-coenzyme A conjugates with cytosolic glutathione S-transferases. Drug Metab Dispos 36: 260-267. (Pubitemid 351185737)
41. Pacifici R, Fiaschi AI, Micheli L, Centini F, Giorgi G, Zuccaro P et al (2003). Immunosuppression and oxidative stress induced by acute and daily exposure to cocaine in rat. Int Immunopharmacol 3: 581-592. (Pubitemid 36419518)
42. Radonjic NV, Knezevic ID, Vilimanovich U, Kravic-Stevovic T, Marina LV, Nikolic T (2010). Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Neuropharmacology 58: 739-745.
43. Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A (2009). Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 33: 1178-1183.
44. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C et al (2006). Dynamic redox control of NF-kB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103: 13086-13091. (Pubitemid 44338920)
45. Schafer FQ, Buettner GR (2001). Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic Biol Med 30: 1191-1212. (Pubitemid 32463931)
46. Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z et al (2009). Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am J Pathol 175: 54-65.
47. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH (2006). Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26: 10514-10523. (Pubitemid 44564602)
48. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F et al (1994). Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36: 348-355. (Pubitemid 24280055)
49. Smeyne M, Boyd J, Raviie Shepherd K, Jiao Y, Pond BB, Hatler M et al (2007). GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc Natl Acad Sci USA 104: 1977-1982. (Pubitemid 46239889)
50. Steullet P, Neijt HC, Cuenod M, Do KQ (2006). Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience 137: 807-819. (Pubitemid 43053945)
51. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M et al (2004). Homer proteins regulate sensitivity to cocaine. Neuron 43: 401-413. (Pubitemid 39061131)
52. Tannenbaum SR, White FM (2006). Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem Biol 1: 615-618.
53. Townsend DM (2007). S-glutathionylation: Indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7: 313-324.
54. Townsend DM, He L, Hutchens S, Garrett TE, Pazoles CJ, Tew KD (2008). NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance. Cancer Res 68: 2870-2877. (Pubitemid 351556286)
55. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, Tew KD (2009). Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress. J Biol Chem 284: 436-445.
56. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict Biol 12: 227-462. (Pubitemid 47196347)
57. Uys JD, Manevich Y, Devane LC, He L, Garret TE, Pazoles CJ et al (2010). Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic. Biomed Pharmacother 64: 493-498.
58. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology (Berl) 151: 99-120. (Pubitemid 30646415)
59. Vilar R, Coelho H, Rodrigues E, Gama MJ, Rivera I, Taioli E et al (2007). Association of A313 G polymorphism (GSTP1.*B) in the glutathione-S- transferase P1 gene with sporadic Parkinson's disease. Eur J Neurol 14: 156-161. (Pubitemid 46148302)
60. Visalli T, Turkall R, Abdel-Rahman MS (2004). Cocaine hepatotoxicity and its potentiation by lipopolysaccharide: Treatment and gender effects. Int J Toxicol 23: 163-170. (Pubitemid 41724513)
61. Zhu Y, Carvey PM, Ling Z (2006). Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res 1090: 35-44. (Pubitemid 43817938)